|
|
 |
|
 |
|
|
|
|
Title:
|
A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting Zoledronic Acid Treatment - IRB# 09-013A
|
|
Treatments:
|
-- none --
|
|
Disease Site:
|
Cancer control
|
|
Disease SubSite:
|
Bone Metastases
|
|
Drug Provided:
|
-- none --
|
|
Comments:
|
|
|
Eligibility:
|
Bone metastasis from multiple myeloma, solid tumor, other malignancy where bisphosphonate is indicated; planned treatment with zoledronic acid; < / = 3 doses IV ibandronate, pamidronate or zoledronic acid in past 3 years for osteopenia or osteoporosis; < / = 90 days IV ibandronate, pamidronate, or zoledronic acid for metastatic bone disease, Zubrod PS 0-3; willing to provide information regarding smoking history, alcohol consumption, pain assessments; willing to undergo dental assessments per protocol; willing to provide access to prior and future dental information; participation in other therapeutic or non-therapeutic trials is o.k.
|
|
Participating Sites:
|
Adventist Medical Center, Northwest Cancer Specialists, Providence Milwaukie Hospital, Providence Portland Medical Center, Providence St. Vincent Medical Center, Southwest Washington Medical Center
|
|
|
|
|
 |
|
 |
|
|
|